Home » Topics » Conferences

Conferences
RSS

Afatinib is active in patients with head and neck and lung cancers

Nov. 3, 2010

Manageable toxicity seen with brivanib alaninate plus cetuximab and irinotecan in colorectal cancer

Nov. 3, 2010

Antibodies targeting LINGO-1 promote myelination in preclinical studies

Nov. 3, 2010

Azathioprine and prednisolone reduce relapse rates in neuromyelitis optica

Nov. 3, 2010

Mild toxicity and disease stabilizations seen with L19TNF-alpha in patients with cancer

Nov. 2, 2010

Effects of denosumab reported in patients with prostate cancer and bone metastases

Nov. 2, 2010

Clinical trials explore efficacy of budesonide in treating eosinophilic esophagitis

Nov. 2, 2010

Data from several studies on mitoxantrone for relapsing-remitting MS made available

Nov. 2, 2010

Rifaximin-EIR induces durable remissions in patients with Crohn's disease

Oct. 29, 2010

BETAPEDIC trial of IFN-beta-1b in juvenile patients with MS is enrolling participants

Oct. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...